AR069521A1 - Sales de propionato de 3 (2,2,2- trimetilhidrazinio) para la profilaxis y el tratamiento de la ateroesclerosis y uso medico - Google Patents

Sales de propionato de 3 (2,2,2- trimetilhidrazinio) para la profilaxis y el tratamiento de la ateroesclerosis y uso medico

Info

Publication number
AR069521A1
AR069521A1 ARP080105237A ARP080105237A AR069521A1 AR 069521 A1 AR069521 A1 AR 069521A1 AR P080105237 A ARP080105237 A AR P080105237A AR P080105237 A ARP080105237 A AR P080105237A AR 069521 A1 AR069521 A1 AR 069521A1
Authority
AR
Argentina
Prior art keywords
prophylaxis
treatment
hydraziny
aterosclerosis
trimethyl
Prior art date
Application number
ARP080105237A
Other languages
English (en)
Inventor
Ilmars Stonans
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40481525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR069521(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of AR069521A1 publication Critical patent/AR069521A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Reivindicacion1: Uso de la sal de propionato de 3-(2,2,2-trimetilhidrazinio) seleccionada del grupo que consiste en fosfato de dihidrogeno y fumarato de hidrogeno para la manufactura de un medicamento para la profilaxis y/o el tratamiento de la aterosclerosis.
ARP080105237A 2007-12-04 2008-12-02 Sales de propionato de 3 (2,2,2- trimetilhidrazinio) para la profilaxis y el tratamiento de la ateroesclerosis y uso medico AR069521A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122272 2007-12-04
EP07122273 2007-12-04

Publications (1)

Publication Number Publication Date
AR069521A1 true AR069521A1 (es) 2010-01-27

Family

ID=40481525

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105237A AR069521A1 (es) 2007-12-04 2008-12-02 Sales de propionato de 3 (2,2,2- trimetilhidrazinio) para la profilaxis y el tratamiento de la ateroesclerosis y uso medico

Country Status (32)

Country Link
US (1) US20100234459A1 (es)
EP (1) EP2222293B1 (es)
JP (1) JP2011505408A (es)
KR (1) KR20100084688A (es)
CN (1) CN101951898B (es)
AR (1) AR069521A1 (es)
AT (1) ATE518536T1 (es)
AU (1) AU2008333262A1 (es)
BR (1) BRPI0819057A2 (es)
CA (1) CA2706354C (es)
CL (1) CL2008003551A1 (es)
CO (1) CO6280477A2 (es)
CY (1) CY1112336T1 (es)
DK (1) DK2222293T3 (es)
DO (1) DOP2010000163A (es)
EA (1) EA019424B1 (es)
GE (1) GEP20125673B (es)
HR (1) HRP20110744T1 (es)
IL (1) IL205961A0 (es)
MA (1) MA31993B1 (es)
MX (1) MX2010006255A (es)
MY (1) MY150508A (es)
PA (1) PA8805901A1 (es)
PE (1) PE20091037A1 (es)
PL (1) PL2222293T3 (es)
PT (1) PT2222293E (es)
RS (1) RS51992B (es)
SI (1) SI2222293T1 (es)
TN (1) TN2010000250A1 (es)
TW (1) TW200930356A (es)
WO (1) WO2009071585A1 (es)
ZA (1) ZA201003641B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425835A1 (en) * 2010-08-18 2012-03-07 Grindeks, a joint stock company A new medical use of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate and natural flavonoid derivatives
TWI487524B (zh) * 2010-12-03 2015-06-11 Tetra Sia 菸鹼酸和米曲肼之新穎治療組合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1667960B1 (en) * 2003-08-04 2008-02-13 "Joint Stock Company Grindeks" Meldonium salts, method of their preparation and pharmaceutical composition on their basis

Also Published As

Publication number Publication date
EP2222293B1 (en) 2011-08-03
MA31993B1 (fr) 2011-01-03
BRPI0819057A2 (pt) 2015-05-05
US20100234459A1 (en) 2010-09-16
CO6280477A2 (es) 2011-05-20
TW200930356A (en) 2009-07-16
CA2706354A1 (en) 2009-06-11
CY1112336T1 (el) 2015-12-09
SI2222293T1 (sl) 2011-12-30
CN101951898A (zh) 2011-01-19
WO2009071585A1 (en) 2009-06-11
ATE518536T1 (de) 2011-08-15
DOP2010000163A (es) 2010-08-31
PE20091037A1 (es) 2009-08-19
EA201000738A1 (ru) 2011-04-29
MX2010006255A (es) 2011-03-15
HRP20110744T1 (hr) 2011-11-30
EP2222293A1 (en) 2010-09-01
PA8805901A1 (es) 2009-07-23
EA019424B1 (ru) 2014-03-31
IL205961A0 (en) 2010-11-30
AU2008333262A1 (en) 2009-06-11
TN2010000250A1 (en) 2011-11-11
PT2222293E (pt) 2011-11-15
GEP20125673B (en) 2012-10-25
RS51992B (en) 2012-04-30
CN101951898B (zh) 2012-12-05
DK2222293T3 (da) 2011-11-21
MY150508A (en) 2014-01-30
JP2011505408A (ja) 2011-02-24
ZA201003641B (en) 2011-03-30
KR20100084688A (ko) 2010-07-27
PL2222293T3 (pl) 2012-01-31
CA2706354C (en) 2013-08-13
CL2008003551A1 (es) 2010-01-22

Similar Documents

Publication Publication Date Title
CR11510A (es) Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer
CY1116927T1 (el) Προφαρμακα της τετραϋδροκανναβινολης, συνθεσεις οι οποιες περιλαμβανουν προφαρμακα της τετραϋδροκανναβινολης και μεθοδοι χρησης των ιδιων
BR112017007144A2 (pt) ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição.
BRPI0407658A (pt) derivados de ácido aminofosfÈnico, seus sais e hidratos que atuam como moduladores de receptor de s1p e agente farmacêutico
UY32030A (es) "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
PA8680701A1 (es) Derivados de oxindol
CO2020013600A2 (es) Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de jak
CL2013001202A1 (es) Metodo para prevenir enfermedades de plantas que comprende aplicar un agente para el tratamiento del suelo, donde el agente comprende compuestos derivados de quinolina o sus sales como ingrediente activo.
AR065392A1 (es) Metodos para el tratamiento por inhalacion de una enfermedad o estado respiratorio
PA8748101A1 (es) Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus
CL2011000806A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
MY174010A (en) Device for extracorporeal blood treatment
CL2011000798A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
RU2012157473A (ru) Способ выявления или лечения реакции "трансплантат против хозяина"
AR111374A1 (es) Uso de lik066 en pacientes con insuficiencia cardíaca
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
AR059838A1 (es) Formulaciones para dosis estabilizantes de estatina
DK2165704T3 (da) Anvendelse af alverin ved behandling af hudsygdomme
AR069521A1 (es) Sales de propionato de 3 (2,2,2- trimetilhidrazinio) para la profilaxis y el tratamiento de la ateroesclerosis y uso medico
BR112015012497A2 (pt) combinações farmacêuticas
AR069548A1 (es) Sales de propionato de 3-(2,2,2- trimetilhidrazinio ) en el tratamiento de la enfermedad cardiaca isquemica y uso medico
UY27910A1 (es) Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca
AR074981A1 (es) Derivados de etan-amina, composiciones farmaceuticas y usos para el tratamiento de depresion
AR061139A1 (es) Tratamiento de los calores subitos con antagonistas del receptor muscarinico

Legal Events

Date Code Title Description
FB Suspension of granting procedure